Research Progress of Ginkgo Biloba Preparation in Off-label Drug Use
10.13748/j.cnki.issn1007-7693.20222891
- VernacularTitle:银杏叶制剂超说明书使用研究进展
- Author:
ZHENG Yachun
1
;
DU Haicheng
1
;
HONG Yichao
1
;
DING Nan
1
;
ZHOU Xin
1
;
WANG Jianfang
1
;
YAO Jianbiao
1
Author Information
1. Zhejiang CONBA Pharmaceutical Co., Ltd., Hangzhou 310052, China
- Publication Type:Journal Article
- Keywords:
Ginkgo biloba;
off-label drug use;
central nervous system disease;
ear disease;
eye disease;
mental illness;
kidney disease
- From:
Chinese Journal of Modern Applied Pharmacy
2023;40(15):2167-2176
- CountryChina
- Language:Chinese
-
Abstract:
Ginkgo biloba preparation is widely used as natural extract preparation both domestically and internationally, for myocardial infarction and cerebral infarction diseases in China; and mainly used to improve memory and treat dementia symptoms abroad. In recent years, there have been a large amount of reports on the treatment of ophthalmic diseases, mental diseases, kidney diseases and so on, however some of which have not uniform literature result. Therefore, it is necessary to summarize the reports on off-label use of Ginkgo biloba preparation. Among them, Ginkgo biloba preparation has a lot of controversy on brain diseases such as dementia and autism, mainly due to the mild effect, the difficulty in tracking long-term medication data for chronic diseases, and the subjective evaluation results of cognitive level, so more high-level research is needed to provide data support. In addition, Ginkgo biloba preparation has obvious protective effects on peripheral nerves and microvascular, and as an adjuvant drug in related diseases, it can effectively accelerate the recovery process of patients. This article summarizes various reports on Ginkgo biloba preparations, which can better clarify the product positioning and provide a reference for the selection of relevant treatment options.
